HomeIDRSF • OTCMKTS
add
Idorsia Ltd
Previous close
$4.95
Year range
$0.70 - $5.82
Market cap
981.56M CHF
Avg Volume
657.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
| (CHF) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 41.49M | 58.35% |
Operating expense | 51.43M | -19.64% |
Net income | -85.68M | 15.20% |
Net profit margin | -206.52 | 46.45% |
Earnings per share | — | — |
EBITDA | -36.04M | 57.06% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.20M | -30.97% |
Total assets | 454.57M | -11.36% |
Total liabilities | 1.59B | -2.97% |
Total equity | -1.14B | — |
Shares outstanding | 232.84M | — |
Price to book | -1.01 | — |
Return on assets | -21.09% | — |
Return on capital | -69.06% | — |
Cash Flow
Net change in cash
| (CHF) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -85.68M | 15.20% |
Cash from operations | -13.96M | 90.28% |
Cash from investing | 2.21M | 279.92% |
Cash from financing | 3.48M | — |
Net change in cash | -8.26M | 94.33% |
Free cash flow | -1.06M | 98.74% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938
